---
schema_version: "secwatch.filing_event.v1"
accession: "0000883984-21-000031"
form_type: "8-K"
ticker: "ICUI"
cik: "0000883984"
company_name: "ICU MEDICAL INC/DE"
filed_at: "2021-11-03T23:59:59+00:00"
generated_at: "2026-06-28T14:44:58.445668+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# ICU Medical Q3 revenue $336.1M (+5.5% YoY); adj. EPS $2.07 vs $1.90

## Summary
- Revenue $336.1M, up from $318.6M in Q3 2020.
- GAAP net income $31.1M ($1.43 diluted) vs $25.0M ($1.16) YoY.
- Adjusted diluted EPS $2.07 vs $1.90 in prior-year quarter.
- Adjusted EBITDA $71.9M, compared to $62.2M in Q3 2020.
- GAAP gross margin improved to 38% from 36% YoY.

## SEC filing metadata
- accession: 0000883984-21-000031
- form_type: 8-K
- ticker: ICUI
- cik: 0000883984
- company_name: ICU MEDICAL INC/DE
- filed_at: 2021-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883984/000088398421000031/0000883984-21-000031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883984/000088398421000031/icui-20211103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000883984-21-000031
- JSON: https://secwatch.observer/filing/0000883984-21-000031.json
- Plain text: https://secwatch.observer/filing/0000883984-21-000031.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.